Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Ophthotech Corp (OPHT) A Good Stock To Buy?

Page 1 of 2

At Insider Monkey we follow around 730 of the best-performing investors and even though many of them lost money in the last several months, the history teaches us that over the long-run they still manage to beat the market, which is why it can be profitable for us to imitate their activity. Of course, even the best money managers can sometimes get it wrong, but following some of their picks gives us a better chance to outperform the crowd than picking a random stock and this is where our research comes in.

Is Ophthotech Corp (NASDAQ:OPHT) a healthy stock for your portfolio? The smart money is in a bearish mood. The number of bullish hedge fund positions shrunk by 1 in recent months. At the end of this article we will also compare OPHT to other stocks, including Mpg Office Trust Inc (NYSE:MPG), Gamco Investors Inc. (NYSE:GBL), and ITI Inc (NASDAQ:ITCI) to get a better sense of its popularity.

Follow Ophthotech Corp. (NASDAQ:OPHT)
Trade (NASDAQ:OPHT) Now!

In today’s marketplace there are plenty of formulas shareholders have at their disposal to evaluate stocks. Some of the less known formulas are hedge fund and insider trading activity. Our experts have shown that, historically, those who follow the best picks of the elite investment managers can outpace the market by a significant margin (see the details here).

Now, let’s check out the fresh action surrounding Ophthotech Corp (NASDAQ:OPHT).

How have hedgies been trading Ophthotech Corp (NASDAQ:OPHT)?

At the end of the third quarter, a total of 18 of the hedge funds tracked by Insider Monkey held long positions in this stock, down by 5% from one quarter earlier. With hedge funds’ capital changing hands, there exists a select group of notable hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).

Of the funds tracked by Insider Monkey, James H. Litinsky’s JHL Capital Group has the largest position in Ophthotech Corp (NASDAQ:OPHT), worth close to $132.3 million, amounting to 14.6% of its total 13F portfolio. The second largest stake is held by OrbiMed Advisors, managed by Samuel Isaly, which holds a $77.9 million position; 0.8% of its 13F portfolio is allocated to the company. Some other professional money managers that are bullish comprise Jim Simons’s Renaissance Technologies, Dmitry Balyasny’s Balyasny Asset Management and James Dondero’s Highland Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!